Evogene (EVGN) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.31), $0.12 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $310 thousand versus the consensus estimate of $575 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Zuckerberg Directed Meta To Create Prediction Markets App - NYT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
